China Universal Asset Management Co., Ltd. Lyell Immunopharma, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.03 Billion
- Q4 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Lyell Immunopharma, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 59,205 shares of LYEL stock, worth $34,930. This represents 0.0% of its overall portfolio holdings.
Number of Shares
59,205
Previous 49,238
20.24%
Holding current value
$34,930
Previous $67,000
44.78%
% of portfolio
0.0%
Previous 0.01%
Shares
15 transactions
Others Institutions Holding LYEL
# of Institutions
120Shares Held
142MCall Options Held
18.1KPut Options Held
200-
Mwg Management Ltd. Washington, DC20.2MShares$11.9 Million30.81% of portfolio
-
Apoletto LTD Washington, DC15.1MShares$8.91 Million42.56% of portfolio
-
Orland Properties LTD Washington, DC15.1MShares$8.91 Million13.96% of portfolio
-
Black Rock Inc. New York, NY13.5MShares$7.96 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$5.94 Million0.0% of portfolio
About Lyell Immunopharma, Inc.
- Ticker LYEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 247,824,992
- Market Cap $146M
- Description
- Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...